학술논문

Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study
Document Type
Article
Source
In The Lancet Haematology October 2018 5(10):e450-e461
Subject
Primary Research
Articles
Language
ISSN
2352-3026